Completed PHASE2 INTERVENTIONAL 1-arm NCT00004136

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

A Phase II Study of Radiofrequency Ablation of Unresectable Liver Tumors

Sponsor: M.D. Anderson Cancer Center

Conditions Liver Cancer Metastatic Cancer

Updated 6 times since 2017 Last updated: Nov 2, 2018 Started: Mar 9, 1998 Primary completion: Jan 25, 2006 Completion: Jan 25, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00004136, this PHASE2 trial focuses on Liver Cancer and Metastatic Cancer and remains completed. Sponsored by M.D. Anderson Cancer Center, it has been updated 6 times since 1998, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Dec 2018 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Dec 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States